BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Pervasis Therapeutics 



Cambridge  Massachusetts    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology






 Company News
Shire plc to Purchase Substantially All Pervasis Therapeutics Assets to Fortify Regenerative Medicine Business for Undisclosed Amount 4/12/2012 7:57:34 AM    More...
Pervasis Therapeutics Announces Positive Preclinical Study Data of Novel Cell Therapy for Treatment of Solid Tumors 4/6/2011 7:49:00 AM    More...
Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting 3/22/2011 7:52:11 AM    More...
Pervasis Therapeutics Receives Orphan Drug Designation in Europe for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis 3/1/2011 8:40:47 AM    More...
Pervasis Therapeutics Receives FDA Fast Track Status for Vascugel(R) to Prevent Arteriovenous Access Failure in Patients Undergoing Hemodialysis 2/8/2011 7:19:25 AM    More...
Pervasis Therapeutics in “Advanced” Talks with Potential Partners for Blood-Vessel Healing Product, CEO Says 2/1/2011 7:08:11 AM    More...
Pervasis Therapeutics to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases 1/20/2011 8:52:28 AM    More...
Pervasis Therapeutics to Develop Novel Cell-Based Approach to Target Tumor Environment, Prevent Cancer Recurrence 1/20/2011 7:57:58 AM    More...
Pervasis Therapeutics Awarded Four Grants Under the Qualifying Therapeutic Discovery Project 11/8/2010 6:28:17 AM    More...
Pervasis Therapeutics Provides Update on Progress of Clinical Program Targeting Peripheral Arterial Disease 6/22/2010 11:49:41 AM    More...
1234

//-->